Endpoint · otherGETclinicalintelpulse.theaslangroupllc.com /api/clinical/deal-signal ?condition=Disease+area+%E2%80%94+e.g.+%22Obesity%22+%7C+%22Cardiovascular%22+%7C+%22Oncology%22+%7C+%22Rare+Neurological%22+%7C+%22Autoimmune%22&deal_type=acquisition+%7C+licensing+%7C+both+%28default%3A+both%29&lang=en+%7C+es+%7C+fr+%7C+de+%7C+ja+%7C+zh+%7C+ko+%7C+pt+%7C+ar+%7C+hi+%28default%3A+en%29&stage=phase2+%7C+phase3+%7C+both+%28default%3A+both%29
Biotech M&A + licensing deal signal for clinical-stage drugs — Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, transaction multiples…
Read more
Biotech M&A + licensing deal signal for clinical-stage drugs — Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, transaction multiples and estimated deal values. Worldwide. For biotech-investing and BD agents.Overview
Grade?
UNRATED
0 of 30 paid calls toward a letter
Price
$0.35 per call
Paid calls
none yet
delivery unknown until someone pays
More info
Seller?
URL
https://clinicalintelpulse.theaslangroupllc.com/api/clinical/deal-signal?condition=Disease+area+%E2%80%94+e.g.+%22Obesity%22+%7C+%22Cardiovascular%22+%7C+%22Oncology%22+%7C+%22Rare+Neurological%22+%7C+%22Autoimmune%22&deal_type=acquisition+%7C+licensing+%7C+both+%28default%3A+both%29&lang=en+%7C+es+%7C+fr+%7C+de+%7C+ja+%7C+zh+%7C+ko+%7C+pt+%7C+ar+%7C+hi+%28default%3A+en%29&stage=phase2+%7C+phase3+%7C+both+%28default%3A+both%29
Seen
first 35 days ago · last 15 days ago
53 free handshakes
Payment
Pays through
x402
Offered on?
algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k, Polygon, eip155:143, eip155:196, Arbitrum, eip155:480, eip155:56, Base USDC, eip155:999, Solana, xrpl:0
Listed on?
Polygon, Arbitrum, Base, Solana
Handshakescomputed 8 days ago
0.728 from 51 free handshakes over 30 days · UNRATED ?
| Component | Weight | Measured | Lower bound ? | Adds | Short ? | Uncertain ? | |
|---|---|---|---|---|---|---|---|
| latency p95costs the most it answered as fast as its class |
0.20 | 0.00 | 0.000 | 0.000 | −0.200 | 0 | |
| liveness it answered at all |
0.60 | 1.00 | 0.879 | 0.528 | 0 | −0.072 | |
| price stability the price stayed where it was listed |
0.20 | 1.00 | 1.000 | 0.200 | 0 | 0 | |
| Composite | 1.00 | 0.728 | gap to 1.000 = 0.272 · 0.200 short · 0.072 uncertain | 0.728 | −0.200 | −0.072 |
Not measured: correctness · nobody paid; honesty · nobody paid; schema conformance · no answer had a published shape to check
BURN_INFREE_TIER_ONLY
Verify it yourself
npx teppi-check https://clinicalintelpulse.theaslangroupllc.com/api/clinical/deal-signal?condition=Disease+area+%E2%80%94+e.g.+%22Obesity%22+%7C+%22Cardiovascular%22+%7C+%22Oncology%22+%7C+%22Rare+Neurological%22+%7C+%22Autoimmune%22&deal_type=acquisition+%7C+licensing+%7C+both+%28default%3A+both%29&lang=en+%7C+es+%7C+fr+%7C+de+%7C+ja+%7C+zh+%7C+ko+%7C+pt+%7C+ar+%7C+hi+%28default%3A+en%29&stage=phase2+%7C+phase3+%7C+both+%28default%3A+both%29curl -s https://api.teppi.xyz/v1/trust/cap_01M1A51TFGNRR70R9H3BX5X366